We are live on ! Find out more
RFM

Royal Fund Management Portfolio holdings

AUM $1.2B
1-Year Est. Return 32.21%
This Fund
S&P 500
This Quarter Est. Return
+6.35%
1 Year Est. Return
+32.21%
3 Year Est. Return
+92.42%
5 Year Est. Return
+97.01%
10 Year Est. Return
–
AUM
$393M
AUM Growth
+$34.4M
Cap. Flow
+$13.4M
Cap. Flow %
3.42%
Top 10 Hldgs %
27.48%
Holding
746
New
73
Increased
176
Reduced
165
Closed
27

Top Buys

Rank Stock Value
1
SPYV icon
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
+$4.14M
2
JCI icon
Johnson Controls International
JCI
+$1.94M
3
VZ icon
Verizon
VZ
+$1.26M
4
UPS icon
United Parcel Service
UPS
+$1.02M
5
BMY icon
Bristol-Myers Squibb
BMY
+$875K

Top Sells

Rank Stock Value
1
DEO icon
Diageo
DEO
+$2.55M
2
UFS
DOMTAR CORPORATION (New)
UFS
+$1.32M
3
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$846K
4
ABBV icon
AbbVie
ABBV
+$837K
5
XOM icon
ExxonMobil
XOM
+$830K

Sector Composition

Rank Sector Weight
1 Technology 10.04%
2 Healthcare 8.86%
3 Consumer Staples 5.96%
4 Energy 5.78%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLT icon
701
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$0 ﹤0.01%
4
– –
TMFC icon
702
Motley Fool 100 Index ETF
TMFC
$2.05B
$0 ﹤0.01%
+6
New +$142
TMQ
703
Trilogy Metals
TMQ
$541M
$0 ﹤0.01%
83
– –
TPR icon
704
Tapestry
TPR
$30.8B
$0 ﹤0.01%
19
-36
-65% -$938
TTNP
705
DELISTED
Titan Pharmaceuticals
TTNP
– –
0
– –
UAL icon
706
United Airlines
UAL
$39.4B
– –
-339
Closed -$29K
UGI icon
707
UGI
UGI
$7.74B
$0 ﹤0.01%
11
– –
USAS
708
Americas Gold and Silver
USAS
$1.29B
– –
0
– –
TONX
709
TON Strategy Co
TONX
$168M
– –
0
– –
VTR icon
710
Ventas
VTR
$48B
$0 ﹤0.01%
14
-26
-65% -$1.63K
WDC icon
711
Western Digital
WDC
$188B
$0 ﹤0.01%
12
– –
WRAP icon
712
Wrap Technologies
WRAP
$103M
$0 ﹤0.01%
100
– –
XHS icon
713
State Street SPDR S&P Health Care Services ETF
XHS
$206M
– –
-32
Closed -$1K
XXII
714
22nd Century Group
XXII
$1.38M
– –
0
– –
ZS icon
715
Zscaler
ZS
$24.5B
$0 ﹤0.01%
+5
New +$232
IRD
716
Opus Genetics
IRD
$306M
$0 ﹤0.01%
1
– –
TVRD
717
Tvardi Therapeutics
TVRD
$19.7M
– –
-1
Closed –
VIVS
718
VivoSim Labs
VIVS
$1.2M
$0 ﹤0.01%
4
– –
ORGS
719
DELISTED
Orgenesis Inc. Common Stock
ORGS
$0 ﹤0.01%
4
– –
MDC
720
DELISTED
M.D.C. Holdings, Inc.
MDC
$0 ﹤0.01%
1
– –
NEPT
721
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
– –
0
– –
LTHM
722
DELISTED
Livent Corporation
LTHM
$0 ﹤0.01%
93
– –
PACW
723
DELISTED
PacWest Bancorp
PACW
$0 ﹤0.01%
15
– –
ZYNE
724
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$0 ﹤0.01%
+50
New +$342
CGRN
725
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$0 ﹤0.01%
+100
New +$336
26 27 28
29
30

Similar funds

FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CA
Callahan Advisors Houston, Texas $1.2B AUM 22.34% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
SGDR
SPX Gestao de Recursos Rio De Janeiro, Brazil $1.2B AUM 59.05% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

Royal Fund Management's Q4 2019 Portfolio in Review

As of Q4 2019, Royal Fund Management held 746 positions worth $393M, up 9.6% from $359M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Royal Fund Management deployed $13.4M of net new capital in Q4 2019, opening 73 new positions and adding to 176 existing holdings. Its largest new stake was Amplify EASI Tactical Growth ETF: 5,000 shares worth $133K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.9% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Diageo, an estimated $2.55M trimmed.

  • Royal Fund Management's largest Q4 2019 buy was Amplify EASI Tactical Growth ETF: 5,000 shares worth $133K.
  • Royal Fund Management added most to State Street SPDR Portfolio S&P 500 Value ETF in Q4 2019, an estimated $4.14M increase.
  • Royal Fund Management's biggest Q4 2019 reduction was Diageo, cutting an estimated $2.55M.
  • Royal Fund Management fully exited First Trust Senior Floating Rate 2022 Target Term Fund Common Shares of Beneficial Interest in Q4 2019, selling an estimated $212K.
  • Royal Fund Management's ten largest holdings make up 27% of its $393M portfolio in Q4 2019.
  • Royal Fund Management opened 73 new positions and closed 27 in Q4 2019.
  • Royal Fund Management's portfolio value rose 9.6% quarter-over-quarter to $393M.

Based on Royal Fund Management's 13F filing for Q4 2019, filed 11 May 2020.